Patents by Inventor Andrea PARADISI

Andrea PARADISI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrostatic doping of a layer of a conductive or non-conductive material
    Patent number: 10947152
    Abstract: The invention relates to a process for permanently electrostatically doping a layer of a conductive or non-conductive material that is deposited on a solid substrate, to the doped material obtained according to this process, and to the use of such a material.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: March 16, 2021
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Abhay Shukla, Johan Biscaras, Andrea Paradisi
  • ELECTROSTATIC DOPING OF A LAYER OF A CONDUCTIVE OR NON-CONDUCTIVE MATERIAL
    Publication number: 20180215658
    Abstract: The invention relates to a process for permanently electrostatically doping a layer of a conductive or non-conductive material that is deposited on a solid substrate, to the doped material obtained according to this process, and to the use of such a material.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 2, 2018
    Inventors: Abhay SHUKLA, Johan BISCARAS, Andrea PARADISI
  • Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
    Patent number: 9895439
    Abstract: Pharmaceutical composition comprising a chemotherapeutic drug and a netrin-1 interfering drug or a vector capable of expressing a netrin-1 interfering drug in vivo, in a pharmaceutically acceptable carrier or vehicle. The chemotherapeutic drug is selected from those able to induce over expression of netrin-1 in cancer cells. The combination is associated with synergic anti-cancer effect.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: February 20, 2018
    Assignee: NETRIS PHARMA
    Inventors: Patrick Mehlen, Andréa Paradisi, Pascale Nony
  • Combined Treatment with Netrin-1 Interfering Drug and Chemotherapeutic Drug
    Publication number: 20150246116
    Abstract: Pharmaceutical composition comprising a chemotherapeutic drug and a netrin-1 interfering drug or a vector capable of expressing a netrin-1 interfering drug in vivo, in a pharmaceutically acceptable carrier or vehicle. The chemotherapeutic drug is selected from those able to induce over expression of netrin-1 in cancer cells. The combination is associated with synergic anti-cancer effect.
    Type: Application
    Filed: September 12, 2013
    Publication date: September 3, 2015
    Inventors: Patrick Mehlen, Andréa Paradisi, Pascale Nony